0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibacterial and Antiviral Clothing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-14T17573
Home | Market Reports | Health
Global Antibacterial and Antiviral Clothing Market Research Report 2024
BUY CHAPTERS

Global Antibacterial and Antiviral Clothing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-14T17573
Report
October 2025
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antibacterial and Antiviral Clothing Market

The global Antibacterial and Antiviral Clothing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Antibacterial and Antiviral Clothing is characterized by its antibacterial and antiviral properties. This function is usually achieved by incorporating antibacterial and antiviral ingredients or technologies into the fabric.
From a downstream perspective, On-Line accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Antibacterial and Antiviral Clothing leading manufacturers including Annil, Hongdou Group, Semir Group, Xin Hee, Bosideng, etc., dominate supply; the top five capture approximately % of global revenue, with Annil leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Antibacterial and Antiviral Clothing market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Antibacterial and Antiviral Clothing Market Report

Report Metric Details
Report Name Antibacterial and Antiviral Clothing Market
Segment by Type
Segment by Application
  • On-Line
  • Off-Line
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Annil, Hongdou Group, Semir Group, Xin Hee, Bosideng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Antibacterial and Antiviral Clothing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Antibacterial and Antiviral Clothing Market report?

Ans: The main players in the Antibacterial and Antiviral Clothing Market are Annil, Hongdou Group, Semir Group, Xin Hee, Bosideng

What are the Application segmentation covered in the Antibacterial and Antiviral Clothing Market report?

Ans: The Applications covered in the Antibacterial and Antiviral Clothing Market report are On-Line, Off-Line

What are the Type segmentation covered in the Antibacterial and Antiviral Clothing Market report?

Ans: The Types covered in the Antibacterial and Antiviral Clothing Market report are Adult Clothing, Children's Clothing

Recommended Reports

Medicinal Applications

Antiviral Treatments

Functional Coatings

1 Study Coverage
1.1 Introduction to Antibacterial and Antiviral Clothing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antibacterial and Antiviral Clothing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Adult Clothing
1.2.3 Children's Clothing
1.3 Market Segmentation by Application
1.3.1 Global Antibacterial and Antiviral Clothing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 On-Line
1.3.3 Off-Line
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antibacterial and Antiviral Clothing Revenue Estimates and Forecasts 2020-2031
2.2 Global Antibacterial and Antiviral Clothing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Antibacterial and Antiviral Clothing Sales Estimates and Forecasts 2020-2031
2.4 Global Antibacterial and Antiviral Clothing Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Antibacterial and Antiviral Clothing Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Antibacterial and Antiviral Clothing Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Adult Clothing Market Size by Manufacturers
3.5.2 Children's Clothing Market Size by Manufacturers
3.6 Global Antibacterial and Antiviral Clothing Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Antibacterial and Antiviral Clothing Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Antibacterial and Antiviral Clothing Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Antibacterial and Antiviral Clothing Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Antibacterial and Antiviral Clothing Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Antibacterial and Antiviral Clothing Sales and Revenue by Type (2020-2031)
6.4 North America Antibacterial and Antiviral Clothing Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Antibacterial and Antiviral Clothing Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Antibacterial and Antiviral Clothing Sales and Revenue by Type (2020-2031)
7.4 Europe Antibacterial and Antiviral Clothing Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Antibacterial and Antiviral Clothing Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Antibacterial and Antiviral Clothing Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Antibacterial and Antiviral Clothing Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Antibacterial and Antiviral Clothing Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Antibacterial and Antiviral Clothing Sales and Revenue by Type (2020-2031)
9.4 Central and South America Antibacterial and Antiviral Clothing Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Antibacterial and Antiviral Clothing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Antibacterial and Antiviral Clothing Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Antibacterial and Antiviral Clothing Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Antibacterial and Antiviral Clothing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Annil
11.1.1 Annil Corporation Information
11.1.2 Annil Business Overview
11.1.3 Annil Antibacterial and Antiviral Clothing Product Models, Descriptions and Specifications
11.1.4 Annil Antibacterial and Antiviral Clothing Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Annil Antibacterial and Antiviral Clothing Sales by Product in 2024
11.1.6 Annil Antibacterial and Antiviral Clothing Sales by Application in 2024
11.1.7 Annil Antibacterial and Antiviral Clothing Sales by Geographic Area in 2024
11.1.8 Annil Antibacterial and Antiviral Clothing SWOT Analysis
11.1.9 Annil Recent Developments
11.2 Hongdou Group
11.2.1 Hongdou Group Corporation Information
11.2.2 Hongdou Group Business Overview
11.2.3 Hongdou Group Antibacterial and Antiviral Clothing Product Models, Descriptions and Specifications
11.2.4 Hongdou Group Antibacterial and Antiviral Clothing Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Hongdou Group Antibacterial and Antiviral Clothing Sales by Product in 2024
11.2.6 Hongdou Group Antibacterial and Antiviral Clothing Sales by Application in 2024
11.2.7 Hongdou Group Antibacterial and Antiviral Clothing Sales by Geographic Area in 2024
11.2.8 Hongdou Group Antibacterial and Antiviral Clothing SWOT Analysis
11.2.9 Hongdou Group Recent Developments
11.3 Semir Group
11.3.1 Semir Group Corporation Information
11.3.2 Semir Group Business Overview
11.3.3 Semir Group Antibacterial and Antiviral Clothing Product Models, Descriptions and Specifications
11.3.4 Semir Group Antibacterial and Antiviral Clothing Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Semir Group Antibacterial and Antiviral Clothing Sales by Product in 2024
11.3.6 Semir Group Antibacterial and Antiviral Clothing Sales by Application in 2024
11.3.7 Semir Group Antibacterial and Antiviral Clothing Sales by Geographic Area in 2024
11.3.8 Semir Group Antibacterial and Antiviral Clothing SWOT Analysis
11.3.9 Semir Group Recent Developments
11.4 Xin Hee
11.4.1 Xin Hee Corporation Information
11.4.2 Xin Hee Business Overview
11.4.3 Xin Hee Antibacterial and Antiviral Clothing Product Models, Descriptions and Specifications
11.4.4 Xin Hee Antibacterial and Antiviral Clothing Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Xin Hee Antibacterial and Antiviral Clothing Sales by Product in 2024
11.4.6 Xin Hee Antibacterial and Antiviral Clothing Sales by Application in 2024
11.4.7 Xin Hee Antibacterial and Antiviral Clothing Sales by Geographic Area in 2024
11.4.8 Xin Hee Antibacterial and Antiviral Clothing SWOT Analysis
11.4.9 Xin Hee Recent Developments
11.5 Bosideng
11.5.1 Bosideng Corporation Information
11.5.2 Bosideng Business Overview
11.5.3 Bosideng Antibacterial and Antiviral Clothing Product Models, Descriptions and Specifications
11.5.4 Bosideng Antibacterial and Antiviral Clothing Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Bosideng Antibacterial and Antiviral Clothing Sales by Product in 2024
11.5.6 Bosideng Antibacterial and Antiviral Clothing Sales by Application in 2024
11.5.7 Bosideng Antibacterial and Antiviral Clothing Sales by Geographic Area in 2024
11.5.8 Bosideng Antibacterial and Antiviral Clothing SWOT Analysis
11.5.9 Bosideng Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Antibacterial and Antiviral Clothing Industry Chain
12.2 Antibacterial and Antiviral Clothing Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Antibacterial and Antiviral Clothing Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Antibacterial and Antiviral Clothing Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Antibacterial and Antiviral Clothing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Antibacterial and Antiviral Clothing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Antibacterial and Antiviral Clothing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Antibacterial and Antiviral Clothing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Antibacterial and Antiviral Clothing Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Antibacterial and Antiviral Clothing Sales by Region (2020-2025) & (Units)
 Table 8. Global Antibacterial and Antiviral Clothing Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Antibacterial and Antiviral Clothing Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Antibacterial and Antiviral Clothing Sales Share by Manufacturers (2020-2025)
 Table 12. Global Antibacterial and Antiviral Clothing Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Antibacterial and Antiviral Clothing Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Antibacterial and Antiviral Clothing by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibacterial and Antiviral Clothing as of 2024)
 Table 16. Global Antibacterial and Antiviral Clothing Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Antibacterial and Antiviral Clothing Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Antibacterial and Antiviral Clothing Manufacturing Base and Headquarters
 Table 19. Global Antibacterial and Antiviral Clothing Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Antibacterial and Antiviral Clothing Sales by Type (2020-2025) & (Units)
 Table 23. Global Antibacterial and Antiviral Clothing Sales by Type (2026-2031) & (Units)
 Table 24. Global Antibacterial and Antiviral Clothing Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Antibacterial and Antiviral Clothing Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Antibacterial and Antiviral Clothing ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Antibacterial and Antiviral Clothing Sales by Application (2020-2025) & (Units)
 Table 29. Global Antibacterial and Antiviral Clothing Sales by Application (2026-2031) & (Units)
 Table 30. Antibacterial and Antiviral Clothing High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Antibacterial and Antiviral Clothing Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Antibacterial and Antiviral Clothing Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Antibacterial and Antiviral Clothing ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Antibacterial and Antiviral Clothing Growth Accelerators and Market Barriers
 Table 37. North America Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Antibacterial and Antiviral Clothing Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Antibacterial and Antiviral Clothing Growth Accelerators and Market Barriers
 Table 40. Europe Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Antibacterial and Antiviral Clothing Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Antibacterial and Antiviral Clothing Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Antibacterial and Antiviral Clothing Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Antibacterial and Antiviral Clothing Investment Opportunities and Key Challenges
 Table 47. Central and South America Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Antibacterial and Antiviral Clothing Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Antibacterial and Antiviral Clothing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Annil Corporation Information
 Table 51. Annil Description and Major Businesses
 Table 52. Annil Product Models, Descriptions and Specifications
 Table 53. Annil Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Annil Sales Value Proportion by Product in 2024
 Table 55. Annil Sales Value Proportion by Application in 2024
 Table 56. Annil Sales Value Proportion by Geographic Area in 2024
 Table 57. Annil Antibacterial and Antiviral Clothing SWOT Analysis
 Table 58. Annil Recent Developments
 Table 59. Hongdou Group Corporation Information
 Table 60. Hongdou Group Description and Major Businesses
 Table 61. Hongdou Group Product Models, Descriptions and Specifications
 Table 62. Hongdou Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Hongdou Group Sales Value Proportion by Product in 2024
 Table 64. Hongdou Group Sales Value Proportion by Application in 2024
 Table 65. Hongdou Group Sales Value Proportion by Geographic Area in 2024
 Table 66. Hongdou Group Antibacterial and Antiviral Clothing SWOT Analysis
 Table 67. Hongdou Group Recent Developments
 Table 68. Semir Group Corporation Information
 Table 69. Semir Group Description and Major Businesses
 Table 70. Semir Group Product Models, Descriptions and Specifications
 Table 71. Semir Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Semir Group Sales Value Proportion by Product in 2024
 Table 73. Semir Group Sales Value Proportion by Application in 2024
 Table 74. Semir Group Sales Value Proportion by Geographic Area in 2024
 Table 75. Semir Group Antibacterial and Antiviral Clothing SWOT Analysis
 Table 76. Semir Group Recent Developments
 Table 77. Xin Hee Corporation Information
 Table 78. Xin Hee Description and Major Businesses
 Table 79. Xin Hee Product Models, Descriptions and Specifications
 Table 80. Xin Hee Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Xin Hee Sales Value Proportion by Product in 2024
 Table 82. Xin Hee Sales Value Proportion by Application in 2024
 Table 83. Xin Hee Sales Value Proportion by Geographic Area in 2024
 Table 84. Xin Hee Antibacterial and Antiviral Clothing SWOT Analysis
 Table 85. Xin Hee Recent Developments
 Table 86. Bosideng Corporation Information
 Table 87. Bosideng Description and Major Businesses
 Table 88. Bosideng Product Models, Descriptions and Specifications
 Table 89. Bosideng Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Bosideng Sales Value Proportion by Product in 2024
 Table 91. Bosideng Sales Value Proportion by Application in 2024
 Table 92. Bosideng Sales Value Proportion by Geographic Area in 2024
 Table 93. Bosideng Antibacterial and Antiviral Clothing SWOT Analysis
 Table 94. Bosideng Recent Developments
 Table 95. Key Raw Materials Distribution
 Table 96. Raw Materials Key Suppliers
 Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 98. Milestones in Production Technology Evolution
 Table 99. Distributors List
 Table 100. Market Trends and Market Evolution
 Table 101. Market Drivers and Opportunities
 Table 102. Market Challenges, Risks, and Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources


List of Figures
 Figure 1. Antibacterial and Antiviral Clothing Product Picture
 Figure 2. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Adult Clothing Product Picture
 Figure 4. Children's Clothing Product Picture
 Figure 5. Global Antibacterial and Antiviral Clothing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. On-Line
 Figure 7. Off-Line
 Figure 8. Antibacterial and Antiviral Clothing Report Years Considered
 Figure 9. Global Antibacterial and Antiviral Clothing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Antibacterial and Antiviral Clothing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Antibacterial and Antiviral Clothing Revenue Market Share by Region (2020-2031)
 Figure 13. Global Antibacterial and Antiviral Clothing Sales (2020-2031) & (Units)
 Figure 14. Global Antibacterial and Antiviral Clothing Sales (CAGR) by Region (2020-2031) (Units)
 Figure 15. Global Antibacterial and Antiviral Clothing Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Antibacterial and Antiviral Clothing Sales Volume Market Share in 2024
 Figure 17. Global Antibacterial and Antiviral Clothing Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Adult Clothing Revenue Market Share by Manufacturer in 2024
 Figure 20. Children's Clothing Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Antibacterial and Antiviral Clothing Sales Market Share by Type (2020-2031)
 Figure 22. Global Antibacterial and Antiviral Clothing Revenue Market Share by Type (2020-2031)
 Figure 23. Global Antibacterial and Antiviral Clothing Sales Market Share by Application (2020-2031)
 Figure 24. Global Antibacterial and Antiviral Clothing Revenue Market Share by Application (2020-2031)
 Figure 25. North America Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
 Figure 26. North America Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
 Figure 28. North America Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2020- 2031)
 Figure 29. North America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
 Figure 31. North America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
 Figure 36. Europe Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2020-2031)
 Figure 39. Europe Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
 Figure 41. Europe Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 43. France Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
 Figure 48. Asia-Pacific Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 58. India Antibacterial and Antiviral Clothing Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
 Figure 60. Central and South America Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2021-2031)
 Figure 63. Central and South America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
 Figure 65. Central and South America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Antibacterial and Antiviral Clothing Sales YoY (2020-2031) & (Units)
 Figure 69. Middle East and Africa Antibacterial and Antiviral Clothing Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Antibacterial and Antiviral Clothing Sales Volume (Units) by Type (2021-2031)
 Figure 72. South America Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Antibacterial and Antiviral Clothing Sales Volume (Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Antibacterial and Antiviral Clothing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Antibacterial and Antiviral Clothing Revenue (2020-2025) & (US$ Million)
 Figure 79. Antibacterial and Antiviral Clothing Industry Chain Mapping
 Figure 80. Regional Antibacterial and Antiviral Clothing Manufacturing Base Distribution (%)
 Figure 81. Global Antibacterial and Antiviral Clothing Production Market Share by Region (2020-2031)
 Figure 82. Antibacterial and Antiviral Clothing Production Process
 Figure 83. Regional Antibacterial and Antiviral Clothing Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners